| Dr George Sinelnik, MD | |
|
500 W Broadway St, Missoula, MT 59802-4008 | |
| (406) 721-5600 | |
| (406) 721-3907 |
| Full Name | Dr George Sinelnik |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 500 W Broadway St, Missoula, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396824702 | NPI | - | NPPES |
| 43342 | Medicaid | MT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | MT 4308 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr George Sinelnik, MD Po Box 7609, Missoula, MT 59807-7609 Ph: (406) 721-5600 | Dr George Sinelnik, MD 500 W Broadway St, Missoula, MT 59802-4008 Ph: (406) 721-5600 |
News Archive
An annual report from the U.S. Consumer Product Safety Commission shows that fireworks-related eye injuries have nearly doubled, from 700 in 2016 to 1,200 in 2017. Overall, fireworks caused nearly 13,000 injuries in 2017, up from 11,000 in 2016.
The researchers selected the human adenovirus type 5 on which to base their vaccine because this replication-defective vector had already been used in their Ebola vaccine, with an excellent safety and immunogenicity profile in a phase 1 trial. The current study aimed to produce a vaccine that could offer mucosal vaccination and enhanced protection against this respiratory virus.
Eisai Inc. announced today that the Phase III ACCESS (A Controlled Comparison of Eritoran and Placebo in Patients with Severe Sepsis) trial of the investigational compound eritoran (E5564) will continue enrolling to the preset goal of 2,000 patients. As part of a planned interim analysis, an independent Data Monitoring Committee (DMC) has evaluated efficacy and safety data on the first 1,500 subjects to complete the 28-day follow-up in the Phase III ACCESS trial.
Experts on the Gene Therapy Advisory Committee have given the go ahead for a large clinical trial of a new treatment for patients with Glioma - one of the most aggressive types of brain tumours for which there is currently no cure.
› Verified 4 days ago
Diana Griffith, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2827 Fort Missoula Rd, Missoula, MT 59804 Phone: 406-728-4100 | |
Dr. Amanda A Morey, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 500 W Broadway St, Missoula, MT 59802 Phone: 406-329-5635 | |
Dr. Kevin Granger Eichhorn, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: Saint Patrick Hospital Emergency Department, 500 West Broadway, Missoula, MT 59801 Phone: 406-329-5635 | |
Elizabeth J Grimley, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 500 W Broadway St, Missoula, MT 59802 Phone: 406-721-5600 Fax: 406-721-3907 | |
David Westphal, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2827 Fort Missoula Rd, Missoula, MT 59804 Phone: 406-721-4800 | |
Dr. Douglas Carl Melzer, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 500 W Broadway St, Missoula, MT 59802 Phone: 303-720-9622 | |
Dr. Robert C Mcdevitt, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 500 W Broadway St, Missoula, MT 59802 Phone: 406-721-5600 Fax: 406-721-3907 |